# The Medicines (Products for Human Use — Fees) Regulations 1991, Regulation 2: Interpretation


(1) In these Regulations, unless the context requires otherwise—
“the Act” means the Medicines Act 1968 and, except as provided below, expressions used in these Regulations have the same meaning as in that Act;
“capital fee” means any fee, other than a periodic fee, payable under the provisions of these Regulations;
“licence fee period” means the period beginning with the coming into force of these Regulations and ending on 31st March 1992 and subsequently, the period beginning with the first day of April in any year and ending with the last day of March in the following year;
“medicinal product” includes any substance or article specified in any order made under section 104 or 105(1)(a) of the Act which directs that Part II of the Act shall have effect in relation to such substance or article;
“periodic fee” means a fee payable under regulation 14;
“product licence (parallel import)” means a product licence in respect of a medicinal product which is imported into the United Kingdom from another Member State of the European Economic Community, in respect of which there has been granted a marketing authorisation in another Member State of that Community and which has no differences having therapeutic effect from a medicinal product in respect of which a product licence has previously been granted in the United Kingdom;
“relevant licence fee period” means any licence fee period during any part of which a licence in respect of which a periodic fee is payable is in force.
(2) The interpretation provisions contained in Part I of Schedule 1 and Parts I and II of Schedule 3 shall have effect.
(3) In these Regulations any reference to a regulation or a Schedule shall be construed as a reference to a regulation contained in these Regulations, or as the case may be, to a Schedule thereto, and any reference in a regulation, Schedule or Part of a Schedule, to a numbered paragraph shall be construed as a reference to a paragraph of that regulation or, as the case may be, Schedule, or Part of a Schedule bearing that number.

---
Source: https://www.legislation.gov.uk/uksi/1991/1474/regulation/2 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1991/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.